OCUL Ocular Therapeutix Inc

Ocular Therapeutix Inc is a biopharmaceutical company. It is engaged in developing and commercializing therapies for diseases and conditions of the eye using its proprietary hydrogel platform technology.

$3.75  -0.36 (-8.76%)
As of 06/28/2022 14:06:09 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  07/25/2014
Outstanding shares:  76,759,614
Average volume:  733,299
Market cap:   $306,270,860
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BNZB1X8
Valuation   (See tab for details)
PE ratio:   -13.79
PB ratio:   3.84
PS ratio:   6.20
Return on equity:   -27.84%
Net income %:   -45.00%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy